Pyxis Oncology enters worldwide agreement with Pfizer to develop and commercialize novel ADCs March 22, 2021
Exelixis collaborates with Merck KGaA and Pfizer to evaluate XL-092 plus avelumab in UC March 19, 2021
T-Cure enters clinical research agreement to support phase I study of KK-LC-1 TCR therapy March 18, 2021
Xenon collaborates with Mount Sinai on phase II study of XEN-1101 for MDD and anhedonia March 9, 2021
ESSA Pharma and Astellas collaborate to investigate EPI-7386 plus enzalutamide in mCRPC Feb. 26, 2021
RSS